Amphastar Pharmaceuticals

$17.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.22 (+1.29%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AMPH and other stocks, options, and ETFs commission-free!

About AMPH

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments.

CEO

Yong Feng Zhang

Employees

1,980

Headquarters

Rancho Cucamonga, California

Founded

1996

Market Cap

854.20M

Price-Earnings Ratio

598.25

Dividend Yield

—

Average Volume

172.81K

High Today

$17.54

Low Today

$17.14

Open Price

$17.14

Volume

156.24K

52 Week High

$22.69

52 Week Low

$15.50

AMPH Earnings

$0.00

$0.06

$0.11

$0.17

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, After Hours